# Developmental Funds

> **NIH NIH P30** · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2020 · $422,774

## Abstract

DEVELOPMENTAL FUNDS 
ABSTRACT 
The Developmental funds of the CCSG represent a vital component of the UAB-CCC Core grant by 
empowering the Center Director to respond to and provide leadership for the strategic scientific needs and 
priorities of the Center. The UAB CCC uses these funds in three primary ways. First, New Investigator funds 
are combined with other Center funds (e.g., gift account) and funds from departments and other Centers to 
provide attractive recruitment packages for faculty important to the Cancer Center's research enterprise. 
These recruitments may represent an enhancement of a new research initiative, expansion of an existing 
program or replacement of departing or retiring faculty. During the current cycle the recruited investigators 
have been awarded over $1.9M in extramural funding. The second use of these funds is for our Pilot Grant 
Program with an emphasis on young or new faculty and inter- and intra-programmatic collaborative research 
programs and seed funding for multi-project grants such as SPOREs and P01s. The CCC contributes to 3-4 
junior faculty grants in collaboration with our American Cancer Society Institutional Research Grant. Our 
Scientific Advisory Committee reviews and critiques these applications for Cancer Center research priorities 
and potential for extramural funding. The recipients of these funds have an excellent track record of successful 
grant funding (more than $4.1M in extramural direct costs) and adding to the scientific growth of our programs. 
Third, development funding is used to invest in new research technologies that the Center membership find of 
significant value yet cannot afford to implement individually. This investment manifests itself as expansion of 
the capabilities of a current shared facility or the creation of a developing shared facilities centered on the new 
technology. In the current funding cycle the Microbiome/Gnotobiotic Shared Facility received Developmental 
Funds as did the Pharamacometrics facility 
During the last funding cycle of the UAB-CCC there were five new investigators supported by CCSG 
Development dollars, seven junior investigators received pilot funding, 6 putative PO1 teams received 
developmental funding, one new developing shared facility was started, and another four received significant 
upgrades in technology. All the efforts of the CCSG Development dollars were implemented to further the 
mission of the Center and provide added value to the CCC membership.

## Key facts

- **NIH application ID:** 9895640
- **Project number:** 5P30CA013148-48
- **Recipient organization:** UNIVERSITY OF ALABAMA AT BIRMINGHAM
- **Principal Investigator:** Barry P Sleckman
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $422,774
- **Award type:** 5
- **Project period:** — → 2022-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9895640

## Citation

> US National Institutes of Health, RePORTER application 9895640, Developmental Funds (5P30CA013148-48). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9895640. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*